Identification of the hub genes in gastric cancer through weighted gene co-expression network analysis

Abstract

Background Gastric cancer is one of the most lethal tumors and is characterized by poor prognosis and lack of effective diagnostic or therapeutic biomarkers. The aim of this study was to find hub genes serving as biomarkers in gastric cancer diagnosis and therapy. Methods GSE66229 from Gene Expression Omnibus (GEO) was used as training set. Genes bearing the top 25% standard deviations among all the samples in training set were performed to systematic weighted gene co-expression network analysis (WGCNA) to find candidate genes. Then, hub genes were further screened by using the “least absolute shrinkage and selection operator” (LASSO) logistic regression. Finally, hub genes were validated in the GSE54129 dataset from GEO by supervised learning method artificial neural network (ANN) algorithm. Results Twelve modules with strong preservation were identified by using WGCNA methods in training set. Of which, five modules significantly related to gastric cancer were selected as clinically significant modules, and 713 candidate genes were identified from these five modules. Then, ADIPOQ, ARHGAP39, ATAD3A, C1orf95, CWH43, GRIK3, INHBA, RDH12, SCNN1G, SIGLEC11 and LYVE1 were screened as the hub genes. These hub genes successfully differentiated the tumor samples from the healthy tissues in an independent testing set through artificial neural network algorithm with the area under the receiver operating characteristic curve at 0.946. Conclusions These hub genes bearing diagnostic and therapeutic values, and our results may provide a novel prospect for the diagnosis and treatment of gastric cancer in the future.

Connecting Cholesterol Efflux Factors to Lung Cancer Biology and Therapeutics

“…In the human genome, STARD3 is less than 30 kilobases away from HER2 on chromosome 17. Thus, it is perhaps not surprising that STARD3 is classically co-amplified and co-expressed with HER2 in approximately 10-25% of breast cancers [79,80]. It has been shown that inducing STARD3 overexpression elevates HER2 positive breast cancer proliferation, and ablating this expression returns an opposite effect [78,81].…”

Stabilized COre gene and Pathway Election uncovers pan-cancer shared pathways and a cancer-specific driver

“…The genes that are highly connected with other genes in the network, called "hub" genes, are expected to be important in pathology (7). As such, many pipelines discovering driver genes incorporate information from coexpression networks and these hub genes into the next phase of multiomics approaches (8)(9)(10). It has, however, been noted that hub genes are not stable, and they are not guaranteed to be driver genes (11).…”

Effects of probiotics on gastric cancer‐related inflammation: A systematic review and meta‐analysis

“…Gastric cancer is the fifth most common type of malignant tumor in the world and the third leading cause of death in cancer patients (Li et al., 2021). At present, surgical treatment is still one of the main measures to treat gastric cancer.…”